Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach § 130 c SGB V zu dem Arzneimittel Inclisiran
GWQ ServicePlus AG awarded €1 to Novartis Pharma GmbH for Healthcare & Medical in February 2026 — one of 207 awards this buyer has made, in line with its typical award size.
Buying agency
GWQ ServicePlus AGWinning supplier
Novartis Pharma GmbHContract description
Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach § 130 c SGB V zu dem Arzneimittel Inclisiran (Leqvio)
Related awards · GWQ ServicePlus AG
207 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-131852-2026neuraxpharm Arzneimittel GmbH€125 Feb 2026 Healthcare
- ocds-ted-133782-2026AstraZeneca GmbH€125 Feb 2026 Healthcare
- ocds-ted-204728-2025Bayer Vital GmbH€131 Mar 2025 Healthcare
Other wins · Novartis Pharma GmbH
6 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-246155-2025DAK-Gesundheit€115 Apr 2025 Healthcare
- ocds-ted-362761-2026GWQ ServicePlus AG€127 May 2026 Healthcare
- ocds-ted-235966-2024-1AOK Rheinland/Hamburg - Die GesundheitskasseNot disclosed22 Apr 2024 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for GWQ ServicePlus AG and Novartis Pharma GmbH — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back